Katherine Cates Panakos
Family Medicine · Derby, KSNPI 1952323842
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 82 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $480 and has fallen 94.9% since, to $25 in 2025.
Across 82 payments — averaging $15.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$205
- Novo Nordisk$205
- AbbVie$157
- Lilly USA, LLC$106
- Johnson & Johnson$79
- Amarin Pharma, Inc.$71
- plus $456 from 14 others
What the payments were for
- Food & beverage$1,279100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 12 | $205 |
| Novo Nordisk | 13 | $205 |
| AbbVie | 9 | $157 |
| Lilly USA, LLC | 8 | $106 |
| Johnson & Johnson | 5 | $79 |
| Amarin Pharma, Inc. | 4 | $71 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $57 |
| Sanofi-aventis U.S. LLC | 4 | $53 |
| AstraZeneca | 4 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| Daiichi Sankyo Inc. | 3 | $43 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $38 |
| Merck | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $31 |
| Abbott | 2 | $26 |
| GSK | 1 | $22 |
| Boehringer Ingelheim | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Pfizer | 1 | $14 |
| Novartis | 1 | $12 |
How this compares
$1,279 in reported general payments places this provider in the 65th percentile of 1,469 family medicine providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Derby
- Glen PattonDerby$11K
- Bradley HarrisonManhattan$314K
- Mila MeansWichita$241K
- Scott AveryJunction City$195K
- Kent KiracofeManhattan$189K
- Terry McGeeneyLeawood$147K
- Cole GillenwaterWichita$62K
- David StricklandLawrence$53K
- Kyle PlatzManhattan$51K
- Eric AspinwallKansas City$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.